Royal Bank of Canada’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Buy |
+43
| New | +$1.56K | ﹤0.01% | 6768 |
|
|
2025
Q2 | – | Sell |
-7
| Closed | – | – | 7379 |
|
|
2025
Q1 | $0 | Sell |
7
-376
| -98% | -$6.28K | ﹤0.01% | 7267 |
|
|
2024
Q4 | $5K | Buy |
383
+87
| +29% | +$1.29K | ﹤0.01% | 6554 |
|
|
2024
Q3 | $4K | Buy |
+296
| New | +$4.91K | ﹤0.01% | 6561 |
|
|
2024
Q2 | – | Sell |
-104
| Closed | -$2K | – | 7584 |
|
|
2024
Q1 | $2K | Sell |
104
-484
| -82% | -$6.16K | ﹤0.01% | 6713 |
|
|
2023
Q4 | $6K | Buy |
588
+581
| +8,300% | +$8.16K | ﹤0.01% | 6628 |
|
|
2023
Q3 | $0 | Buy |
7
+4
| +133% | +$98 | ﹤0.01% | 7652 |
|
|
2023
Q2 | $0 | Sell |
3
-9
| -75% | -$286 | ﹤0.01% | 7697 |
|
|
2023
Q1 | $0 | Buy |
12
+9
| +300% | +$305 | ﹤0.01% | 7525 |
|
|
2022
Q4 | $0 | Sell |
3
-1
| -25% | -$33 | ﹤0.01% | 7771 |
|
|
2022
Q3 | $0 | Buy |
4
+1
| +33% | +$39 | ﹤0.01% | 7915 |
|
|
2022
Q2 | $0 | Sell |
3
-1
| -25% | -$26 | ﹤0.01% | 7750 |
|
|
2022
Q1 | $0 | Sell |
4
-1
| -20% | -$30 | ﹤0.01% | 8046 |
|
|
2021
Q4 | $0 | Buy |
5
+1
| +25% | +$54 | ﹤0.01% | 7918 |
|
|
2021
Q3 | $0 | Sell |
4
-12
| -75% | -$904 | ﹤0.01% | 7899 |
|
|
2021
Q2 | $1K | Sell |
16
-23
| -59% | -$2.33K | ﹤0.01% | 7351 |
|
|
2021
Q1 | $4K | Buy |
39
+15
| +63% | +$1.47K | ﹤0.01% | 7119 |
|
|
2020
Q4 | $2K | Buy |
24
+9
| +60% | +$690 | ﹤0.01% | 6881 |
|
|
2020
Q3 | $2K | Buy |
15
+7
| +88% | +$615 | ﹤0.01% | 6347 |
|
|
2020
Q2 | $1K | Sell |
8
-4
| -33% | -$395 | ﹤0.01% | 6492 |
|
|
2020
Q1 | $1K | Buy |
12
+4
| +50% | +$385 | ﹤0.01% | 6500 |
|
|
2019
Q4 | $1K | Buy |
8
+3
| +60% | +$182 | ﹤0.01% | 6694 |
|
|
2019
Q3 | $0 | Buy |
+5
| New | +$282 | ﹤0.01% | 7164 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 6968 |
|
|
2018
Q2 | $0 | Buy |
+3
| New | +$222 | ﹤0.01% | 6792 |
|
|
2018
Q1 | – | Sell |
-2
| Closed | -$490 | – | 6828 |
|
|
2017
Q4 | $0 | Sell |
2
-13
| -87% | -$2.92K | ﹤0.01% | 6924 |
|
|
2017
Q3 | $4K | Buy |
+15
| New | +$2.99K | ﹤0.01% | 6474 |
|
|
2017
Q2 | – | Sell |
-6
| Closed | -$1.25K | – | 6788 |
|
|
2017
Q1 | $1K | Sell |
6
-5
| -45% | -$1.14K | ﹤0.01% | 6530 |
|
|
2016
Q4 | $2K | Buy |
+11
| New | +$2.53K | ﹤0.01% | 6492 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 6677 |
|
|
2015
Q4 | $0 | Sell |
1
-4
| -80% | -$1.12K | ﹤0.01% | 6837 |
|
|
2015
Q3 | $1K | Buy |
+5
| New | +$1.74K | ﹤0.01% | 6517 |
|
Other funds holding VTVT
SB
SL
BBA
TECP
VCM
VFT
Royal Bank of Canada's VTVT Position: Q1 2026 in Review
Royal Bank of Canada opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 43 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #6768 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in VTVT as recently as Q1 2025.
Royal Bank of Canada first reported a position in VTVT in Q3 2015 and has held it in 30 quarters since. The position peaked at $6K in Q4 2023. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.
- Royal Bank of Canada held 43 shares of vTv Therapeutics worth $2K as of Q1 2026.
- vTv Therapeutics was a new Royal Bank of Canada position in Q1 2026.
- vTv Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6768 holding.
- Royal Bank of Canada first reported a position in vTv Therapeutics in Q3 2015 and has held it in 30 quarters since.
- Royal Bank of Canada's vTv Therapeutics position peaked at $6K in Q4 2023.
- 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.